People with NNRTI resistance have poorer responses to dolutegravir, South African study finds
Two different cases of PrEP failure despite high adherence underline that such events are rare, but should not be ignored
“Unprecedented” case of transmission of four-class resistant HIV virus reported in France
Recycling tenofovir better than switch to second-line zidovudine
High levels of drug resistance among infants newly diagnosed with HIV in sub-Saharan Africa
Delaying treatment changes when first-line ART fails costs lives, says South African study
Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds
Does PrEP cause more HIV drug resistance? Yes, some
Proviral DNA resistance testing allows treatment switches without viral rebound
